First Coast Cardiovascular Institute, PA

Jacksonville, Florida 32256-6954

3 studies enrolling now · 9 studies all time

What they study most

Arteriovenous Fistula, Coronary Heart Disease (CHD), Critical Limb Ischemia, End-stage Renal Disease, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure With Left Bundle Branch Block, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Kidney Disease, End-Stage, Lower Extremity Arterial Disease, Obesity

Studies at this site

• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System — Recruiting now
• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure — Completed
• AdaptResponse Clinical Trial — Completed
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed
• EverFlex Post Approval Study — Completed
• Evaluation of the GORE TIGRIS Vascular Stent — Completed